The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Next-Generation Oncology Solution Market Research Report 2025
Synopsis
Next-generation oncology solutions refer to the advanced and innovative technologies, treatments, and approaches used to diagnose, treat, and manage cancer more effectively and efficiently. These solutions aim to improve patient outcomes, enhance precision medicine, and streamline oncology care by leveraging cutting-edge technologies and personalized treatment approaches.
Global Next-Generation Oncology Solution market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next-Generation Oncology Solution market research.
The global market for next-generation oncology solutions has been witnessing substantial growth and innovation, driven by advancements in genomics, precision medicine, immunotherapy, and data analytics. These cutting-edge solutions are transforming cancer care by providing more personalized and effective treatment options for patients. The rising incidence of cancer worldwide is propelling the demand for advanced oncology solutions that can offer better treatment outcomes and improved patient care. Precision medicine approaches, which use genomic testing and targeted therapies, have gained prominence, driving the adoption of next-gen oncology solutions. The United States, in particular, is a major market for next-gen oncology solutions due to its robust research and development infrastructure, extensive clinical trials, and high cancer incidence. European countries have been early adopters of precision medicine and advanced oncology treatments, contributing to the growth of the market in this region. The Asia-Pacific region is witnessing significant growth in the oncology market, with countries like China, India, and Japan investing in healthcare infrastructure and research. The global market for next-generation oncology solutions is expected to continue its growth trajectory in the coming years. As technology continues to advance, precision medicine becomes more personalized, and immunotherapy gains further momentum, next-gen oncology solutions are likely to play an increasingly significant role in cancer care. Moreover, collaborations between pharmaceutical companies, research institutions, and healthcare providers are likely to drive innovation and accelerate the development and adoption of next-gen oncology treatments worldwide.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Next-Generation Oncology Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina
PerkinElmer
Thermo Fisher Scientific
Roche Holding
Agilent Technologies
Paige
GE Healthcare
Varian
Brainlab
Qiagen
Hologic
Pacific Biosciences
AstraZeneca
BGI Group
Segment by Type
Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
Software
Others
Segment by Application
Hospitals
Diagnostic Imaging Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next-Generation Oncology Solution report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Next-generation oncology solutions refer to the advanced and innovative technologies, treatments, and approaches used to diagnose, treat, and manage cancer more effectively and efficiently. These solutions aim to improve patient outcomes, enhance precision medicine, and streamline oncology care by leveraging cutting-edge technologies and personalized treatment approaches.
Global Next-Generation Oncology Solution market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next-Generation Oncology Solution market research.
The global market for next-generation oncology solutions has been witnessing substantial growth and innovation, driven by advancements in genomics, precision medicine, immunotherapy, and data analytics. These cutting-edge solutions are transforming cancer care by providing more personalized and effective treatment options for patients. The rising incidence of cancer worldwide is propelling the demand for advanced oncology solutions that can offer better treatment outcomes and improved patient care. Precision medicine approaches, which use genomic testing and targeted therapies, have gained prominence, driving the adoption of next-gen oncology solutions. The United States, in particular, is a major market for next-gen oncology solutions due to its robust research and development infrastructure, extensive clinical trials, and high cancer incidence. European countries have been early adopters of precision medicine and advanced oncology treatments, contributing to the growth of the market in this region. The Asia-Pacific region is witnessing significant growth in the oncology market, with countries like China, India, and Japan investing in healthcare infrastructure and research. The global market for next-generation oncology solutions is expected to continue its growth trajectory in the coming years. As technology continues to advance, precision medicine becomes more personalized, and immunotherapy gains further momentum, next-gen oncology solutions are likely to play an increasingly significant role in cancer care. Moreover, collaborations between pharmaceutical companies, research institutions, and healthcare providers are likely to drive innovation and accelerate the development and adoption of next-gen oncology treatments worldwide.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Next-Generation Oncology Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina
PerkinElmer
Thermo Fisher Scientific
Roche Holding
Agilent Technologies
Paige
GE Healthcare
Varian
Brainlab
Qiagen
Hologic
Pacific Biosciences
AstraZeneca
BGI Group
Segment by Type
Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
Software
Others
Segment by Application
Hospitals
Diagnostic Imaging Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next-Generation Oncology Solution report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Oncology Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
1.2.3 Software
1.2.4 Others
1.3 Market by Application
1.3.1 Global Next-Generation Oncology Solution Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostic Imaging Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Oncology Solution Market Perspective (2018-2029)
2.2 Next-Generation Oncology Solution Growth Trends by Region
2.2.1 Global Next-Generation Oncology Solution Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Next-Generation Oncology Solution Historic Market Size by Region (2018-2023)
2.2.3 Next-Generation Oncology Solution Forecasted Market Size by Region (2024-2029)
2.3 Next-Generation Oncology Solution Market Dynamics
2.3.1 Next-Generation Oncology Solution Industry Trends
2.3.2 Next-Generation Oncology Solution Market Drivers
2.3.3 Next-Generation Oncology Solution Market Challenges
2.3.4 Next-Generation Oncology Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next-Generation Oncology Solution Players by Revenue
3.1.1 Global Top Next-Generation Oncology Solution Players by Revenue (2018-2023)
3.1.2 Global Next-Generation Oncology Solution Revenue Market Share by Players (2018-2023)
3.2 Global Next-Generation Oncology Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next-Generation Oncology Solution Revenue
3.4 Global Next-Generation Oncology Solution Market Concentration Ratio
3.4.1 Global Next-Generation Oncology Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Oncology Solution Revenue in 2022
3.5 Next-Generation Oncology Solution Key Players Head office and Area Served
3.6 Key Players Next-Generation Oncology Solution Product Solution and Service
3.7 Date of Enter into Next-Generation Oncology Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next-Generation Oncology Solution Breakdown Data by Type
4.1 Global Next-Generation Oncology Solution Historic Market Size by Type (2018-2023)
4.2 Global Next-Generation Oncology Solution Forecasted Market Size by Type (2024-2029)
5 Next-Generation Oncology Solution Breakdown Data by Application
5.1 Global Next-Generation Oncology Solution Historic Market Size by Application (2018-2023)
5.2 Global Next-Generation Oncology Solution Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Next-Generation Oncology Solution Market Size (2018-2029)
6.2 North America Next-Generation Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Next-Generation Oncology Solution Market Size by Country (2018-2023)
6.4 North America Next-Generation Oncology Solution Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next-Generation Oncology Solution Market Size (2018-2029)
7.2 Europe Next-Generation Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Next-Generation Oncology Solution Market Size by Country (2018-2023)
7.4 Europe Next-Generation Oncology Solution Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Oncology Solution Market Size (2018-2029)
8.2 Asia-Pacific Next-Generation Oncology Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Next-Generation Oncology Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific Next-Generation Oncology Solution Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next-Generation Oncology Solution Market Size (2018-2029)
9.2 Latin America Next-Generation Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Next-Generation Oncology Solution Market Size by Country (2018-2023)
9.4 Latin America Next-Generation Oncology Solution Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Oncology Solution Market Size (2018-2029)
10.2 Middle East & Africa Next-Generation Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Next-Generation Oncology Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa Next-Generation Oncology Solution Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Next-Generation Oncology Solution Introduction
11.1.4 Illumina Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Detail
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Next-Generation Oncology Solution Introduction
11.2.4 PerkinElmer Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.2.5 PerkinElmer Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Next-Generation Oncology Solution Introduction
11.3.4 Thermo Fisher Scientific Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Roche Holding
11.4.1 Roche Holding Company Detail
11.4.2 Roche Holding Business Overview
11.4.3 Roche Holding Next-Generation Oncology Solution Introduction
11.4.4 Roche Holding Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.4.5 Roche Holding Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Next-Generation Oncology Solution Introduction
11.5.4 Agilent Technologies Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.5.5 Agilent Technologies Recent Development
11.6 Paige
11.6.1 Paige Company Detail
11.6.2 Paige Business Overview
11.6.3 Paige Next-Generation Oncology Solution Introduction
11.6.4 Paige Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.6.5 Paige Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Next-Generation Oncology Solution Introduction
11.7.4 GE Healthcare Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.7.5 GE Healthcare Recent Development
11.8 Varian
11.8.1 Varian Company Detail
11.8.2 Varian Business Overview
11.8.3 Varian Next-Generation Oncology Solution Introduction
11.8.4 Varian Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.8.5 Varian Recent Development
11.9 Brainlab
11.9.1 Brainlab Company Detail
11.9.2 Brainlab Business Overview
11.9.3 Brainlab Next-Generation Oncology Solution Introduction
11.9.4 Brainlab Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.9.5 Brainlab Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Next-Generation Oncology Solution Introduction
11.10.4 Qiagen Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.10.5 Qiagen Recent Development
11.11 Hologic
11.11.1 Hologic Company Detail
11.11.2 Hologic Business Overview
11.11.3 Hologic Next-Generation Oncology Solution Introduction
11.11.4 Hologic Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.11.5 Hologic Recent Development
11.12 Pacific Biosciences
11.12.1 Pacific Biosciences Company Detail
11.12.2 Pacific Biosciences Business Overview
11.12.3 Pacific Biosciences Next-Generation Oncology Solution Introduction
11.12.4 Pacific Biosciences Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.12.5 Pacific Biosciences Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Detail
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Next-Generation Oncology Solution Introduction
11.13.4 AstraZeneca Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.13.5 AstraZeneca Recent Development
11.14 BGI Group
11.14.1 BGI Group Company Detail
11.14.2 BGI Group Business Overview
11.14.3 BGI Group Next-Generation Oncology Solution Introduction
11.14.4 BGI Group Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.14.5 BGI Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
